A qualitative assessment of factors influencing acceptance of a new rotavirus vaccine among health care providers and consumers

BACKGROUND: In 2006, a new rotavirus vaccine (RotaTeq) was licensed in the US and recommended for routine immunization of all US infants. Because a previously licensed vaccine (Rotashield) was withdrawn from the US for safety concerns, identifying barriers to uptake of RotaTeq will help develop stra...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Manish M, Janssen, Alan P, Tardif, Richard R, Herring, Mark, Parashar, Umesh D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2203981/
https://www.ncbi.nlm.nih.gov/pubmed/17945010
http://dx.doi.org/10.1186/1471-2431-7-32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2203981/
https://www.ncbi.nlm.nih.gov/pubmed/17945010
http://dx.doi.org/10.1186/1471-2431-7-32

Ejemplares similares